The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of KRAS alterations in localized pancreatic cancer (PC).
 
Aditya Varnam Shreenivas
No Relationships to Disclose
 
Kaitlin Annunzio
No Relationships to Disclose
 
Mandana Kamgar
No Relationships to Disclose
 
Sakti Chakrabarti
Honoraria - Haliodx
 
James P. Thomas
No Relationships to Disclose
 
Srivats Madhavan
No Relationships to Disclose
 
Kulwinder Dua
No Relationships to Disclose
 
Abdul H. Khan
No Relationships to Disclose
 
William Adrian Hall
Research Funding - Elekta (Inst)
Travel, Accommodations, Expenses - Elekta (Inst)
 
Beth Erickson
Research Funding - Elekta (Inst)
Travel, Accommodations, Expenses - Elekta (Inst)
 
Kathleen K. Christians
No Relationships to Disclose
 
Callisia Clarke
No Relationships to Disclose
 
Douglas B. Evans
No Relationships to Disclose
 
Susan Tsai
No Relationships to Disclose
 
Aniko Szabo
No Relationships to Disclose
 
Raul Urrutia
No Relationships to Disclose
 
Michael T Zimmermann
No Relationships to Disclose
 
Honey V Reddi
No Relationships to Disclose
 
Ben George
Honoraria - Newlink Genetics
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Cook Medical; Eisai; Exelixis; Foundation Medicine; Ipsen; Merrimack; Taiho Pharmaceutical; TERUMO
Research Funding - Boehringer Ingelheim (Inst); CeGaT (Inst); Celgene (Inst); Eisai (Inst); Foundation Medicine (Inst); Roche (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst)